VANGUARD GROUP INC - HUMACYTE INC ownership

HUMACYTE INC's ticker is and the CUSIP is 44486Q103. A total of 84 filers reported holding HUMACYTE INC in Q3 2023. The put-call ratio across all filers is 63.87 and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of HUMACYTE INC
ValueSharesWeighting
Q3 2023$8,845,573
+4.2%
3,018,967
+1.7%
0.00%
Q2 2023$8,490,299
-7.4%
2,968,636
+0.1%
0.00%
Q1 2023$9,165,796
+52.7%
2,966,277
+4.3%
0.00%
Q4 2022$6,003,505
-31.0%
2,845,263
+6.5%
0.00%
Q3 2022$8,707,000
+1.4%
2,671,123
-0.1%
0.00%
Q2 2022$8,584,000
-49.8%
2,674,005
+10.4%
0.00%
Q1 2022$17,099,000
+101.9%
2,422,020
+107.3%
0.00%
Q4 2021$8,469,000
+151.5%
1,168,232
+302.7%
0.00%
Q3 2021$3,368,000290,1090.00%
Other shareholders
HUMACYTE INC shareholders Q3 2023
NameSharesValueWeighting ↓
Lion Point Capital, LP 235,000$688,5500.31%
Endowment Wealth Management, Inc. 97,518$285,7280.26%
Imprint Wealth LLC 47,072$137,9210.12%
Prescott General Partners LLC 568,246$1,664,9610.11%
GSA CAPITAL PARTNERS LLP 355,918$1,0430.09%
United Asset Strategies, Inc. 143,808$421,3570.05%
HAMILTON LANE ADVISORS LLC 21,893$64,1460.04%
Shay Capital LLC 65,110$190,7720.03%
CLOUGH CAPITAL PARTNERS L P 79,309$232,3750.02%
Powell Investment Advisors, LLC 12,000$35,1600.02%
View complete list of HUMACYTE INC shareholders